Skip to main content

AZTA

Stock
Health Care
Medical Instruments & Supplies

Performance overview

AZTA Price
Price Chart

Forward-looking statistics

Beta
0.95
Risk
42.75%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

azenta (nasdaq: azta) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. azenta is headquartered in chelmsford, ma, with operations in north america, europe and asia. for more information, please visit www.azenta.com.

Company info

SectorHealth Care
IndustryMedical Instruments & Supplies
Employees2K
Market cap$2.9B

Fundamentals

Enterprise value—
Revenue—
Revenue per employee—
Profit margin—
Debt to equity—

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)—
Dividend per share—
Revenue per share—
Avg trading volume (30 day)—
Avg trading volume (10 day)—
Put-call ratio—

Macro factor sensitivity

Growth+1.7
Credit+4.8
Liquidity-0.6
Inflation-2.6
Commodities+0.1
Interest Rates-2.6

Valuation

Dividend yield0.00%
PEG Ratio—
Price to sales—
P/E Ratio69.29
Enterprise Value to Revenue—
Price to book—

Upcoming events

Next earnings dayAugust 5, 2025
Next dividend day—
Ex. dividend day—

News

Is the Options Market Predicting a Spike in Azenta (AZTA) Stock?

Investors need to pay close attention to Azenta (AZTA) stock based on the movements in the options market lately.

Zacks Investment Research (March 6, 2025)
Final Trade: BABA, GOOGL, AZTA, GDX

The final trades of the day with the Fast Money traders.

CNBC Television (November 22, 2024)
Activist Politan Capital engages with Azenta. Here's how the firm may boost shareholder value

Azenta is sitting on a pile of cash, and shareholders will want to know the company's plans for the money.

CNBC (September 30, 2023)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free